References
A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96(1), 53–58 (2011). doi:10.1210/jc.2010-2704
H. Fuleihan Gel, R. Bouillon, B. Clarke, M. Chakhtoura, C. Cooper, M. McClung, R.J. Singh, Serum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range. J. Bone Miner. Res. 30(7), 1119–1133 (2015). doi:10.1002/jbmr.2536
C.J. Rosen, J.S. Adams, D.D. Bikle, D.M. Black, M.B. Demay, J.E. Manson, M.H. Murad, C.S. Kovacs, The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 33(3), 456–492 (2012). doi:10.1210/er.2012-1000
L. Cianferotti, C. Cricelli, J.A. Kanis, R. Nuti, J.Y. Reginster, J.D. Ringe, R. Rizzoli, M.L. Brandi, The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine 50(1), 12–26 (2015). doi:10.1007/s12020-015-0606-x
S. Christakos, M. Hewison, D.G. Gardner, C.L. Wagner, I.N. Sergeev, E. Rutten, A.G. Pittas, R. Boland, L. Ferrucci, D.D. Bikle, Vitamin D: beyond bone. Ann. N. Y. Acad. Sci. 1287, 45–58 (2013). doi:10.1111/nyas.12129
D.D. Bikle, Vitamin D and cancer: the promise not yet fulfilled. Endocrine 46(1), 29–38 (2014). doi:10.1007/s12020-013-0146-1
R. Bouillon, L. Verlinden, Does a better vitamin D status help to reduce cardiovascular risks and events?. Endocrine 47(3), 662–663 (2014). doi:10.1007/s12020-014-0429-1
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H.F. Luderer, L. Lieben, C. Mathieu, M. Demay, Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29(6), 726–776 (2008). doi:10.1210/er.2008-0004
S. Christakos, P. Dhawan, A. Verstuyf, L. Verlinden, G. Carmeliet, Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol. Rev. 96(1), 365–408 (2016). doi:10.1152/physrev.00014.2015
C. Carlberg, Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 5, 167 (2014). doi:10.3389/fphys.2014.00167
R.M. Evans, The nuclear receptor superfamily: a rosetta stone for physiology. Mol. Endocrinol. 19(6), 1429–1438 (2005). doi:10.1210/me.2005-0046
Y. Wang, B.R. Becklund, H.F. DeLuca, Identification of a highly specific and versatile vitamin D receptor antibody. Arch. Biochem. Biophys. 494(2), 166–177 (2010). doi:10.1016/j.abb.2009.11.029
Y. Wang, H.F. DeLuca, Is the vitamin D receptor found in muscle? Endocrinology 152(2), 354–363 (2011). doi:10.1210/en.2010-1109
Y. Wang, J. Zhu, H.F. DeLuca, Where is the vitamin D receptor? Arch. Biochem. Biophys. 523(1), 123–133 (2012). doi:10.1016/j.abb.2012.04.001
F.M. Damiani, R.M. Martin, A.C. Latronico, B. Ferraz-de-Souza, Normal bone mass and normocalcemia in adulthood despite homozygous vitamin D receptor mutations. Osteoporos. Int. 26(6), 1819–1823 (2015). doi:10.1007/s00198-015-3076-3
B. Ferraz-de-Souza, P.L.F. Costa, M.L. Katayama, E.T. Carneiro, M.A. Folgueira, M.M. França, Opposing vitamin D receptor activity in the absence of 1,25-dihydroxyvitamin D. (2016 submitted).
L.T. Campos, H. Brentani, R.A. Roela, M.L. Katayama, L. Lima, C.F. Rolim, C. Milani, M.A. Folgueira, M.M. Brentani, Differences in transcriptional effects of 1α,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues. J. Steroid Biochem. Mol. Biol. 133, 12–24 (2013). doi:10.1016/j.jsbmb.2012.08.002
B. Ferraz-de-Souza, F. Martin, D. Mallet, R.E. Hudson-Davies, P. Cogram, L. Lin, D. Gerrelli, F. Beuschlein, Y. Morel, A. Huebner, J.C. Achermann, CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. J. Clin. Endocrinol. Metab. 94(2), 678–683 (2009). doi:10.1210/jc.2008-1064
Acknowledgments
This work was supported by the Sao Paulo Research Foundation (Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP) Young Investigator grant number 2011/12696-4 (to B.F.-d.-S.) and the FAPESP scientific elective scholarship IC 2014/03561-6 (to P.L.F.C). We are grateful to Maria Lucia Katayama (LIM-24, FMUSP) for kindly providing CYP24A1 oligonucleotides and to Rodrigo Talada Iborra and team at LIM-10, HCFMUSP, for technical assistance with immunoblot imaging.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Costa, P.L.F., França, M.M. & Ferraz-de-Souza, B. Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health. Endocrine 54, 556–559 (2016). https://doi.org/10.1007/s12020-016-1036-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1036-0